Blog

ProVent Study

October 1st, 2018
ProVent Study

ProVent Study is a randomized Phase 3, Open-label Trial of Sipuleucel-T administered to patients on active surveillance for newly diagnosed prostate cancer.
What is the ProVent Study?
The ProVent study is a randomized, open-label study designed to look at whether sipuleucel-T can slow the progression of prostate cancer for subjects in active surveillance, following sipuleucel-T therapy.

OAB Nerve Stimulation Treatment

September 19th, 2018
OAB Nerve Stimulation Treatment

Overactive Bladder (OAB) is a condition involving bothersome urinary symptoms including involuntary leakage of urine. OAB affects between 7% and 27% of men, and 9% and 43% of women. However, involuntary leakage of urine this is associated with a sudden need to urinate, is more common in women.

Prostate Cancer Screening & Treatment

September 17th, 2018
Prostate Cancer Screening & Treatment

The term “cancer” refers to a condition in which cells accumulate uncontrollably—the ability to regulate cell growth or death is lost. So instead of dying as they should, prostate cancer cells live longer than normal cells and form masses of abnormal cells known as tumors.

Control Your bladder, Don’t Let Your Bladder Control You

September 3rd, 2018
Control Your bladder, Don’t Let Your Bladder Control You

Going to the bathroom often? waking up all night?  Need to stop at every gas station? These can all be signs of an underlying bladder condition known as overactive bladder.
Control Your bladder, Don’t Let Your Bladder Control You
Overactive Bladder
Overactive bladder is a common condition that may affect 15% of American women, spanning all adult age groups.

Dr. Amandeep Mahal

August 30th, 2018
Dr. Amandeep Mahal

The practitioners at Adult and Pediatric Urology and Urogynecology have made it their mission to enhance their patients’ quality of life. Featuring nine partners, including Dr. Amandeep Mahal, the prestigious clinic treats all manner of urologic conditions in women and men.